NO20014926D0 - Pharmaceutical compounds - Google Patents
Pharmaceutical compoundsInfo
- Publication number
- NO20014926D0 NO20014926D0 NO20014926A NO20014926A NO20014926D0 NO 20014926 D0 NO20014926 D0 NO 20014926D0 NO 20014926 A NO20014926 A NO 20014926A NO 20014926 A NO20014926 A NO 20014926A NO 20014926 D0 NO20014926 D0 NO 20014926D0
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical compounds
- pharmaceutical
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C07C327/34—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups with amino groups bound to the same hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
- C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/14—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 6 and unsubstituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999MI000750A IT1311921B1 (en) | 1999-04-13 | 1999-04-13 | PHARMACEUTICAL COMPOUNDS. |
| PCT/EP2000/003237 WO2000061549A2 (en) | 1999-04-13 | 2000-04-11 | Pharmaceutical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20014926D0 true NO20014926D0 (en) | 2001-10-10 |
| NO20014926L NO20014926L (en) | 2001-12-13 |
Family
ID=11382682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20014926A NO20014926L (en) | 1999-04-13 | 2001-10-10 | Pharmaceutical compounds |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1192129A2 (en) |
| JP (1) | JP2002541242A (en) |
| KR (1) | KR20020005671A (en) |
| CN (1) | CN1356981A (en) |
| AU (1) | AU3820000A (en) |
| BR (1) | BR0009701A (en) |
| CA (1) | CA2370406A1 (en) |
| HU (1) | HUP0200747A3 (en) |
| IL (1) | IL145632A0 (en) |
| IT (1) | IT1311921B1 (en) |
| MX (1) | MXPA01010209A (en) |
| NO (1) | NO20014926L (en) |
| PL (1) | PL351241A1 (en) |
| TR (1) | TR200102939T2 (en) |
| WO (1) | WO2000061549A2 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1311924B1 (en) * | 1999-04-13 | 2002-03-20 | Nicox Sa | PHARMACEUTICAL COMPOUNDS. |
| CA2393724A1 (en) | 1999-12-23 | 2001-06-28 | Nitromed, Inc. | Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| AU7007001A (en) | 2000-06-22 | 2002-01-02 | Nitromed Inc | Nitrosated and nitrosylated taxanes, compositions and methods of use |
| US6706724B2 (en) | 2000-12-21 | 2004-03-16 | Nitromed, Inc. | Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| EP1406608B1 (en) | 2001-05-02 | 2009-07-29 | Nitromed, Inc. | Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| JP2006501161A (en) | 2002-06-11 | 2006-01-12 | ニトロメッド インク． | Nitrosated and / or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| AU2003247792B2 (en) | 2002-07-03 | 2009-09-24 | Nicox S.A. | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| EP1542972A4 (en) | 2002-07-29 | 2008-01-23 | Nitromed Inc | Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| US20040191803A1 (en) * | 2002-11-22 | 2004-09-30 | Michela Gallagher | Target for therapy of cognitive impairment |
| WO2005070006A2 (en) * | 2004-01-22 | 2005-08-04 | Nitromed, Inc. | Nitrosated and/or nitrosylated compounds, compositions and methods of use |
| KR100678287B1 (en) | 2005-06-23 | 2007-02-02 | 한미약품 주식회사 | Method of preparing clopidogrel and intermediates used therein |
| CN100404543C (en) * | 2006-09-21 | 2008-07-23 | 浙江海正药业股份有限公司 | Intermediate of synthesized pirilmycin, preparation method and usage |
| US20120115824A1 (en) * | 2009-04-17 | 2012-05-10 | Vidasym, Llc | Vitamin D Receptor Agonists and Uses Thereof |
| US9598383B2 (en) * | 2013-06-26 | 2017-03-21 | The Regents Of The University Of California | Reactive oxygen species-based prodrugs |
| CN107418989A (en) * | 2017-08-21 | 2017-12-01 | 浙江工业大学 | A kind of method of lipase-catalyzed online synthesis N (5 sucrose ester valeryl) metoprolol |
| CN113209065B (en) * | 2021-03-29 | 2023-06-20 | 中国科学院西北高原生物研究所 | Use of alkaloid compounds for the production of products for the prevention and/or treatment of heart damage |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1134458B (en) * | 1980-11-26 | 1986-08-13 | Real Sas Di Alberto Reiner | N-ACETYL-CISTEIN DERIVATIVE FOR THERAPEUTIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS |
| IT1190987B (en) * | 1982-09-07 | 1988-02-24 | Pharma Edmond Srl | ACETYLSALICYLIC ACID THIOESTERS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| ES8609231A1 (en) * | 1985-12-03 | 1986-09-01 | Farmhispania | Antiinflammatory N-acetyl-benzoyl-mercapto-alanine prepn. |
| IT1213301B (en) * | 1986-07-14 | 1989-12-20 | Zambon Spa | COMPOSITIONS FOR THE TREATMENT OF SYNDROMES FROM ISCHEMIA AND REPERFUSION |
| DE59712694D1 (en) * | 1997-04-18 | 2006-08-24 | Fritz Stanislaus | STABILIZED MEDICAMENT CONTAINING CYSTEINYL DERIVATIVES |
-
1999
- 1999-04-13 IT IT1999MI000750A patent/IT1311921B1/en active
-
2000
- 2000-04-11 BR BR0009701-2A patent/BR0009701A/en not_active IP Right Cessation
- 2000-04-11 MX MXPA01010209A patent/MXPA01010209A/en unknown
- 2000-04-11 CN CN00808855A patent/CN1356981A/en active Pending
- 2000-04-11 TR TR2001/02939T patent/TR200102939T2/en unknown
- 2000-04-11 JP JP2000610825A patent/JP2002541242A/en active Pending
- 2000-04-11 HU HU0200747A patent/HUP0200747A3/en unknown
- 2000-04-11 PL PL00351241A patent/PL351241A1/en not_active Application Discontinuation
- 2000-04-11 AU AU38200/00A patent/AU3820000A/en not_active Abandoned
- 2000-04-11 WO PCT/EP2000/003237 patent/WO2000061549A2/en not_active Application Discontinuation
- 2000-04-11 KR KR1020017012971A patent/KR20020005671A/en not_active Application Discontinuation
- 2000-04-11 EP EP00917074A patent/EP1192129A2/en not_active Withdrawn
- 2000-04-11 IL IL14563200A patent/IL145632A0/en unknown
- 2000-04-11 CA CA002370406A patent/CA2370406A1/en not_active Abandoned
-
2001
- 2001-10-10 NO NO20014926A patent/NO20014926L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI990750A1 (en) | 2000-10-13 |
| HUP0200747A3 (en) | 2003-02-28 |
| CA2370406A1 (en) | 2000-10-19 |
| IL145632A0 (en) | 2002-06-30 |
| CN1356981A (en) | 2002-07-03 |
| NO20014926L (en) | 2001-12-13 |
| PL351241A1 (en) | 2003-04-07 |
| KR20020005671A (en) | 2002-01-17 |
| AU3820000A (en) | 2000-11-14 |
| EP1192129A2 (en) | 2002-04-03 |
| HUP0200747A2 (en) | 2002-06-29 |
| TR200102939T2 (en) | 2002-09-23 |
| BR0009701A (en) | 2002-04-02 |
| MXPA01010209A (en) | 2003-07-21 |
| WO2000061549A3 (en) | 2002-01-03 |
| JP2002541242A (en) | 2002-12-03 |
| WO2000061549A2 (en) | 2000-10-19 |
| IT1311921B1 (en) | 2002-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20015175D0 (en) | Pharmaceutical composition | |
| ATE392890T1 (en) | HYDROGEL-CONTROLLED DOSAGE FORM | |
| EE200100502A (en) | Compounds | |
| EE200200033A (en) | New compounds | |
| PT1242087E (en) | PHARMACEUTICAL COMPOSITIONS | |
| EE200200224A (en) | Novel compounds | |
| IS6139A (en) | New compounds | |
| NO20015670D0 (en) | Improved pharmaceutical formulations | |
| NO20022606D0 (en) | Pharmaceutical combinations | |
| PT1210085E (en) | LEVOSIMENDANO PHARMACEUTICAL SOLUTIONS | |
| NO20015510D0 (en) | Medication for local application | |
| NO20014926D0 (en) | Pharmaceutical compounds | |
| PT1239832E (en) | PHARMACEUTICAL COMPOSITIONS | |
| NO20013769D0 (en) | Calcilitic compounds | |
| FI4488U1 (en) | Pharmaceutical composition | |
| NO20020466D0 (en) | Calcilitic compounds | |
| PT1227817E (en) | AQUOSA PHARMACEUTICAL COMPOSITION CYCLOSONIDE CONTAINING | |
| IS6141A (en) | New compounds | |
| EE200100697A (en) | Pharmaceutical complex | |
| AR025867A1 (en) | PHARMACEUTICAL PORTASDORA FORMULATION | |
| NO20014262D0 (en) | Tiazoloindolinon compounds | |
| ID29984A (en) | BIS-STIRILBIFENIL COMPOUNDS | |
| SE9902945D0 (en) | Pharmaceuticals | |
| SE9902941D0 (en) | Pharmaceuticals | |
| SE9902939D0 (en) | Pharmaceuticals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |